These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7784418)

  • 1. [RU 486: current and potential indications. Great expectations and strong resistance].
    Serfaty D
    Presse Med; 1995 Apr; 24(16):775-8. PubMed ID: 7784418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigestogens.
    Baird DT
    Br Med Bull; 1993 Jan; 49(1):73-87. PubMed ID: 8324617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mifepristone (RU486): a review.
    Mahajan DK; London SN
    Fertil Steril; 1997 Dec; 68(6):967-76. PubMed ID: 9418681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiprogesterones.
    Norman J
    Br J Hosp Med; 1991 Jun; 45(6):372-5. PubMed ID: 2070168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical uses of antiprogestogens.
    Van Look PF; von Hertzen H
    Hum Reprod Update; 1995 Jan; 1(1):19-34. PubMed ID: 9080204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RU 486. The progesterone antagonist.
    Weiss BD
    Arch Fam Med; 1993 Jan; 2(1):63-9; discussion 70. PubMed ID: 8252138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mifepristone (RU 486): present status, prospectives].
    Peyron R; Ulmann A; Baulieu EE
    Presse Med; 1995 Feb; 24(6):295-8. PubMed ID: 7899389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiprogestins: mechanism of action and contraceptive potential.
    Spitz IM; Croxatto HB; Robbins A
    Annu Rev Pharmacol Toxicol; 1996; 36():47-81. PubMed ID: 8725382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mifepristone: a potential clinical agent based on its anti-progesterone and anti-glucocorticoid properties.
    Sun Y; Fang M; Davies H; Hu Z
    Gynecol Endocrinol; 2014 Mar; 30(3):169-73. PubMed ID: 24205903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RU 486 (mifepristone). A short overview of its mechanisms of action and clinical uses at the end of 1996.
    Baulieu EE
    Ann N Y Acad Sci; 1997 Sep; 828():47-58. PubMed ID: 9329823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RU 486: an alternative to surgical abortion.
    Donaldson K; Briggs J; McMaster D
    J Obstet Gynecol Neonatal Nurs; 1994 Sep; 23(7):555-9. PubMed ID: 7996306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RU 486: an overview of mifepristone and its potential applications.
    Contracept Rep; 1993 May; 4(2):7-9. PubMed ID: 12286473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical pharmacokinetics of mifepristone.
    Heikinheimo O
    Clin Pharmacokinet; 1997 Jul; 33(1):7-17. PubMed ID: 9250420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mifepristone: contraceptive and non-contraceptive uses.
    Ho PC; Yu Ng EH; Tang OS
    Curr Opin Obstet Gynecol; 2002 Jun; 14(3):325-30. PubMed ID: 12032390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Application of anti-progesterone agents for contraception].
    Taketani Y; Mizuno M
    Rinsho Fujinka Sanka; 1988; 42(11):997-1000. PubMed ID: 12283954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The fundamental basis and obstetrical applications of mifepristone or RU-486 (voluntary interrupted pregnancies excluded)].
    Winer N; Lopez P; Sagot P; Boog G
    Rev Fr Gynecol Obstet; 1993 Feb; 88(2):73-7. PubMed ID: 8469867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mifepristone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential.
    Brogden RN; Goa KL; Faulds D
    Drugs; 1993 Mar; 45(3):384-409. PubMed ID: 7682909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The value of RU-486 (mifepristone) in medical indications of the induction of labor at term. Results of a double-blind randomized prospective study (RU-486 versus placebo)].
    Lelaidier C; Benifla JL; Fernandez H; Baton C; Bourget P; Bourrier MC; Frydman R
    J Gynecol Obstet Biol Reprod (Paris); 1993; 22(1):91-100. PubMed ID: 8463575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mifepristone: antineoplastic studies.
    Sartor O; Figg WD
    Clin Obstet Gynecol; 1996 Jun; 39(2):498-505. PubMed ID: 8734014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiprogestins and the abortion controversy: a progress report.
    Klitsch M
    Fam Plann Perspect; 1991; 23(6):275-82. PubMed ID: 1786809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.